Michelle Thomas
Family · Detroit, MINPI 1306994090
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,265 of the $36,146 with a category attached, or 64.4%. Gilead accounts for 96.1% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $13,773, 4.9 times the $2,798 reported in 2021. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $137.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$35K
- Viiv Healthcare Company$500
- AbbVie$159
- Merck$151
- Genentech USA, Inc.$125
- Janssen Products, LP$99
- plus $384 from 8 others
What the payments were for
- Consulting fees$1,3204%
- Speaking & faculty fees$23,26564%
- Travel & lodging$6,44418%
- Food & beverage$4,99014%
- Education$1270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 174 | $34,728 |
| Viiv Healthcare Company | 52 | $500 |
| AbbVie | 6 | $159 |
| Merck | 8 | $151 |
| Genentech USA, Inc. | 1 | $125 |
| Janssen Products, LP | 1 | $99 |
| Novo Nordisk | 4 | $82 |
| Neurocrine Biosciences, Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Indivior Inc. | 2 | $49 |
| Johnson & Johnson(2 entities) | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| GSK | 2 | $28 |
| Qiagen, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,146 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 83 | $327,048 |
| SerostimSomatropin | 13 | $264,618 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 65 | $257,531 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 48 | $218,674 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 49 | $169,162 |
| RukobiaFostemsavir Tromethamine | 16 | $139,998 |
| CabenuvaCabotegravir/Rilpivirine | 17 | $113,234 |
| DovatoDolutegravir Sodium/Lamivudine | 38 | $111,006 |
| TivicayDolutegravir Sodium | 43 | $91,621 |
| JulucaDolutegravir/Rilpivirine | 22 | $82,734 |
| DescovyEmtricitabine/Tenofov Alafenam | 37 | $80,193 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 117 | $79,668 |
| EliquisApixaban | 59 | $36,587 |
| PrezcobixDarunavir/Cobicistat | 12 | $27,637 |
| TrulicityDulaglutide | 21 | $23,833 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $34,728 | $664,772185 claims |
| Viiv Healthcare CompanyRukobia, Cabenuva, Dovato, Tivicay, Juluca | $500 | $538,593136 claims |
| Janssen Products, LPSymtuza | $99 | $218,67448 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $28 | $87,738140 claims |
| Johnson & JohnsonPrezcobix | $42 | $27,63712 claims |
| AbbVieCreon | $159 | $13,28112 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $38 | $53660 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Detroit
- Elisheva EllenbergDetroit$150K
- Danielle BlakeDetroit$34K
- Lauren JuddDetroit$15K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.